Alamar Biosciences Inc recorded no insider trading activity within the past ninety days. The most recent transactions occurred on April 20, 2026, when Illumina Innovation Fund II GP, L.L.C. and Nicholas Naclerio each purchased 235,294 shares. These acquisitions represent the latest documented movements by company insiders.